Printer-friendly version

Satellite Sessions

The satellite sessions below were held on Monday, 12 September prior to the start of the Special Session. 


08:30 – 10:30

An AIDS-Free Africa Through an Effective Vaccine - prospects, progress and challenges


Session Agenda -- Open Session
Host Institutions: The African AIDS Vaccine Partnership (AAVP), The Global Vaccine Enterprise and AVAC
Session Chairs: Dr. Saladin Osmanov and Dr. Alash'le Abimiku


The AAVP satellite meeting aims to bring together all stakeholders attending the Conference to critically appraise the progress towards an AIDS vaccine that can be used in Africa.  The overall Goal is to identify gaps in Africa's response to HIV Vaccine R&D, with the following objectives:

  1. Provide a forum for engagement of scientists and community activists with a view to identifying obstacles to effective participation of African stakeholders in HIV Vaccine R&D.
  2. Disseminate AAVP's new strategic direction and plans to all stakeholders, and to seek input of participants on ways of enhancing the AAVP's relevance to the different stakeholders.

08:30 – 15:00

Global Perspectives, Global Action: Addressing Critical Regulatory Issues in AIDS Vaccine Research. A Collaborative Satellite Symposium at the AIDS Vaccine 2011 Conference.
By Invitation Only

Host Institutions: The Global HIV Vaccine Enterprise, The World Health Organization-UNAIDS, The Canadian HIV Vaccine Initiative (CHVI)


The Regulatory Satellite Symposium will bring together researchers and regulators to discuss regulatory issues and challenges associated with HIV vaccine clinical trials in low and middle income countries (LMICs).

Experiences from the RV144 clinical trial in Thailand and similar experiences from clinical trials internationally will be used to identify key issues.

Results of the discussions at the symposium will feed into the development of an action plan that will highlight key regulatory issues to be addressed in the next five years in order to strengthen global, ethical, legal, and regulatory frameworks as highlighted in the 2010 Strategic Scientific Plan.

08:30 – 15:30

Moving Forward Together: Research Literacy and Community Engagement in 2011 and Beyond 

Session Flyer -- Open Session

Session Considerations


Host Institutions: Thai NGO Coalition on AIDS (TNCA), IAVI, AVAC, HVTN, US Military HIV Research Program-Armed Forces Research Institute of Medical Sciences, and UNAIDS


This interactive session will provide advocates, researchers and community stakeholders an opportunity to learn the basics of research; updates on recent AIDS vaccine and HIV prevention research results; a review of the updated Good Participatory Practice Guidelines; and a discussion of priority issues for Thai and international advocates moving forward.


This session will include interactive capacity-building sessions and roundtable discussions with community leaders, researchers and advocates. The session will help attendees identify key issues in the evolving research agenda and context for the conference.


This session take place in English with Thai translation.  Lunch will be provided.  



12:00 – 15:30

Gathering Sexual Risk Information in HIV Biomedical Prevention Trials – An Offering of Best Practices
Session Agenda -- Open Session


Host InstitutionsUS Agency for International Development (USAID); International AIDS Vaccine Initiative (IAVI); UNAIDS; US Military HIV Research Program (MHRP); Vaccine Research Center (VRC/NIAID); Perinatal Health Research Unit (PHRU), Mahidol University, and Division of AIDS (DAIDS/NIAID).


Session ChairsMargaret M. McCluskey (USAID); Sagri Singh (IAVI); Catherine Hankins (UNAIDS); Glenda Grey (PHRU); Anjali Kunz (WRAIR/MHRP), Patricia Morgan (MHRP); Brenda Larkin (VRC/NIAID); Punnee Pitisuttithum, Jittima Dhitavat (Mahidol University); Edith Swann (DAIDS/NIAID)

Accurately characterizing trial participants’ sexual risk is critical in the context of determining the efficacy of an experimental biomedical or behavioral intervention. Clinicians, researchers, statisticians and regulators struggle to reach reliable sexual risk categories derived from information offered by study participants. Sexual Risk Activity Assessment (SRAA) requires carefully developed skills and may benefit from a hybrid approach. During this satellite, presenters representing vaccine, PrEP and microbicide trials will offer focused discussion and examples of best practices for SRAA from their respective programs from a variety of clinical and socio-cultural settings, while identifying areas that require future research.